UTv Videos

Sandip M. Prasad, MD, MPhil, shares his thoughts on the impact of the FDA approval of mitomycin for intravesical solution for patients with LG-IR-NMIBC.

Jennifer A. Robles, MD, MPH, highlights potential factors contributing to the surge in HoLEP utilization across the US.

Suzanne B. Merrill, MD, FACS explains the challenges with BCG monotherapy and the emergence of novel regimens combining BCG with ICIs in high-risk NMIBC.

Timothy D. McClure, MD, discusses focal therapy with IRE, specifically highlighting its benefits and limitations compared with other treatment options.

Policy availability varied by specialty, with urology leading in program-specific policies—yet still only at 11%.

Jansen underscores the need for urologists to go beyond symptom treatment and focus on identifying root causes of testosterone deficiency.

Aleece Fosnight, MSPAS, PA-C, emphasizes that any patient presenting with urinary incontinence or related symptoms should be evaluated for pelvic floor dysfunction.

Findlay advocated for comprehensive patient counseling that includes the full range of BMS options, not just those available within a provider’s immediate practice.

Jennifer A. Robles, MD, MPH, discusses a study assessing trends and geographic disparities in HoLEP utilization across the United States.

Joseph Song, MD, details his experience using the CVAC device for SURE procedures.

Sonam Saxena highlights a study on factors that may predict failure of robotic ureteroplasty with buccal mucosa graft.

From a practical standpoint, integrating ctDNA into clinical practice poses challenges.

Jansen stresses that testosterone is not a cure-all and often requires adjunct evaluation and management of other conditions such as sleep apnea or thyroid disorders.

Ashley G. Winter, MD, reflects on the need for FDA approved testosterone formulations in women, emphasizing that urologists are well-positioned to drive change in this space.

Vikram M. Narayan, MD, FACS, offers advice for institutions that are considering investments in technology to improve clinical workflows.

A key diagnostic clue is that individuals with disordered eating often have unusually precise awareness of their food and fluid intake.

Sonam Saxena discusses recent findings on trends in surgery vs active surveillance for localized kidney cancer.

“Right now, it is our counseling against the warning label,” Winter emphasized.

Katherine Chan, MD, MPH, details the design of the pivotal phase 1/2 LEGEND trial, assessing the safety and efficacy of detalimogene voraplasmid in NMIBC.

Findlay notes that urinary diversion has increased over time, potentially due to functional decline and growing burdens on patients and caregivers.

Beyond clinical metrics, Pezzella praised the device’s user-friendly, sophisticated design.

"We are not offering patients comprehensive management unless we consider hormone therapies," says Ashley G. Winter, MD.

According to Song, novel aspiration technologies are reshaping not only care delivery, but also long-term treatment outcomes.

Aleece Fosnight, MSPAS, PA-C, CSC-S, CSE, IF, MSCP, HAES, discusses the strong connection between eating disorders and urinary incontinence in women.

One crucial recommendation is incorporating an ergonomic training module into the curriculum.

Betty Wang, MD, said she envisions ctDNA integrating into existing surveillance protocols for patients with high-risk NMIBC.

One consideration is the setting in which the procedure is performed.

The research identified several risk factors for high burnout, including younger age, female gender, and longer working hours.